Purpose: Obesity and metabolic syndrome have a profound impact on gastrointestinal health, contributing to conditions such as fatty liver disease, GERD, IBS, and colorectal cancer. As global prevalence rises, there is growing demand for integrated GI–metabolic care models that combine diagnostics, endoscopic interventions, pharmacotherapy, nutrition, and lifestyle management.
Upload here: https://gastroenterology-hepatology.utilitarianevents.com/upload-presentation/
WhatsApp: https://wa.me/+971551792927
Email: info-ucg@utilitarianconferences.com
Keynote Points:
Rapid growth of obesity and metabolic syndrome worldwide
Strong link between metabolic disorders and GI diseases
Expansion of integrated GI–metabolic clinics and care pathways
High demand for metabolic diagnostics, imaging, and biomarkers
Growth in endoscopic, pharmacologic, and lifestyle-based interventions
Opportunities for digital health and remote metabolic monitoring
Collaboration across GI, endocrinology, nutrition, and wellness sectors
Benefits:
Access to a large and expanding chronic patient population
Multiple revenue streams across diagnostics, procedures, drugs, and wellness programs
High ROI potential through integrated, long-term care models
Differentiation through holistic metabolic–GI healthcare offerings
Strong investor interest in metabolic and preventive care markets
Sustainable growth aligned with value-based and preventive healthcare trends